{"id":"W2793950156","doi":"10.1136/rmdopen-2017-000582","title":"4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis","year":2018,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland; Toronto Western Hospital","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Placebo; Internal medicine; Arthritis; Oncology; Rheumatoid arthritis; Alternative medicine; Adalimumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003721227,0.0002061231,0.001135876,0.00005883035,0.0001391065,0.00004693464,0.0002853403,0.00008670388,0.0009115037],"category_scores_gemma":[0.001348633,0.0001308329,0.0001985919,0.0001903561,0.0001433369,0.00008972239,0.0001504546,0.0001320786,0.000117693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005816775,"about_ca_system_score_gemma":0.0001539739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002360502,"about_ca_topic_score_gemma":0.001476,"domain_scores_codex":[0.9979765,0.0002535507,0.0008036844,0.0003620491,0.0003103539,0.0002938627],"domain_scores_gemma":[0.9981,0.0008512794,0.0002696827,0.0005818059,0.0001073715,0.00008980587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9614699,0.0009435131,0.000083692,0.0000045494,0.0004251282,0.0001957851,0.001412514,1.310627e-7,0.00007255767,0.00002471797,0.003547981,0.03181955],"study_design_scores_gemma":[0.9905292,0.003047034,0.0004398473,0.000295404,0.0002340097,0.0000183818,0.000483417,0.00006139071,0.0005438815,0.0001574696,0.004068932,0.0001210699],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9520319,0.001150985,0.000004913897,0.002863513,0.0008128402,0.01205199,0.0002493717,0.000021999,0.03081254],"genre_scores_gemma":[0.9967932,0.0008484707,0.0002068554,0.000113756,0.0006704557,0.0006740167,0.00008940557,0.00002344657,0.0005803762],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04476137,"threshold_uncertainty_score":0.9980326,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02728568028452725,"score_gpt":0.3212008936669828,"score_spread":0.2939152133824556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}